MHRA’s advice to FreeStyle Libre users experiencing skin reactions
Posted on 30 January 2019
Skin reactions to the sensor adhesive used in the FreeStyle Libre flash glucose monitor devices have been reported to the Medicine and Healthcare products Regulatory Agency (MHRA) which regulates all medicines and medical devices.
Users who are experiencing the symptoms, which include redness, itching or blistering, are advised by the MHRA not to apply creams, sprays or use patches under their device, as this may affect its performance. They should instead seek guidance from their healthcare professional.
Freestyle Libre manufacturer, Abbott, has confirmed it will be revising the formulation of the adhesive it uses in its flash device – which will be available to users of the device in the UK from April 2019 – and has issued the following statement:
“It is important to note that this issue is not unique to the Abbott FreeStyle Libre sensor adhesive… If customers using FreeStyle Libre are experiencing skin sensitivity reaction, Abbott advises users, in accordance with the Instructions for Use, to discontinue use of the Sensor and discuss if continued use of the FreeStyle Libre is appropriate with a Health Care Professional.”
For further information please see the MHRA’s full statement.
Discover our research
Browse our world-class research projects that will transform the lives of people with type 1 diabetes - improving treatments until we find the cureOur research